Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 119

1.

Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.

Park S, Willingham M, Qi J, Cheng SY.

Endocr Relat Cancer. 2018 Jun 18. pii: ERC-18-0071. doi: 10.1530/ERC-18-0071. [Epub ahead of print]

PMID:
29914872
2.

Analysis of Thyroid Tumorigenesis in Xenograft Mouse Model.

Zhu X, Cheng SY.

Methods Mol Biol. 2018;1801:207-223. doi: 10.1007/978-1-4939-7902-8_17.

PMID:
29892827
3.

Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.

Thakur S, Daley B, Gaskins K, Vasko VV, Boufraqech M, Patel D, Sourbier C, Reece J, Cheng SY, Kebebew E, Agarwal S, Klubo-Gwiezdzinska J.

Clin Cancer Res. 2018 Apr 24. doi: 10.1158/1078-0432.CCR-17-3167. [Epub ahead of print]

PMID:
29691295
4.

Mechanisms Linking Obesity and Thyroid Cancer Development and Progression in Mouse Models.

Kim WG, Cheng SY.

Horm Cancer. 2018 Apr;9(2):108-116. doi: 10.1007/s12672-017-0320-7. Epub 2018 Jan 19. Review.

PMID:
29352404
5.

NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.

Han CR, Park S, Cheng SY.

Sci Rep. 2017 Dec 22;7(1):18080. doi: 10.1038/s41598-017-18409-4.

6.

Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer.

Zhu X, Cheng SY.

Endocrinol Metab (Seoul). 2017 Sep;32(3):326-331. doi: 10.3803/EnM.2017.32.3.326. Review.

7.

Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene.

Park S, Han CR, Park JW, Zhao L, Zhu X, Willingham M, Bodine DM, Cheng SY.

PLoS Genet. 2017 Sep 14;13(9):e1006991. doi: 10.1371/journal.pgen.1006991. eCollection 2017 Sep.

8.

Thyroid Hormone Receptor Alpha is Essential to Maintain the Satellite Cell Niche During Skeletal Muscle Injury and Sarcopenia of Aging.

Milanesi A, Lee JW, Yang A, Liu YY, Sedrakyan S, Cheng SY, Perin L, Brent GA.

Thyroid. 2017 Oct;27(10):1316-1322. doi: 10.1089/thy.2017.0021.

PMID:
28847239
9.

Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production.

Hine C, Kim HJ, Zhu Y, Harputlugil E, Longchamp A, Matos MS, Ramadoss P, Bauerle K, Brace L, Asara JM, Ozaki CK, Cheng SY, Singha S, Ahn KH, Kimmelman A, Fisher FM, Pissios P, Withers DJ, Selman C, Wang R, Yen K, Longo VD, Cohen P, Bartke A, Kopchick JJ, Miller R, Hollenberg AN, Mitchell JR.

Cell Metab. 2017 Jun 6;25(6):1320-1333.e5. doi: 10.1016/j.cmet.2017.05.003.

10.

Catch and Release of Cytokines Mediated by Tumor Phosphatidylserine Converts Transient Exposure into Long-Lived Inflammation.

Oyler-Yaniv J, Oyler-Yaniv A, Shakiba M, Min NK, Chen YH, Cheng SY, Krichevsky O, Altan-Bonnet N, Altan-Bonnet G.

Mol Cell. 2017 Jun 1;66(5):635-647.e7. doi: 10.1016/j.molcel.2017.05.011.

11.

Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature.

Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, Yen PM, Refetoff S.

Endocrinology. 2017 Jul 1;158(7):2052-2057. doi: 10.1210/en.2017-00250.

PMID:
28472304
12.

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.

Jang JY, Choi SY, Park I, Park DY, Choe K, Kim P, Kim YK, Lee BJ, Hirashima M, Kubota Y, Park JW, Cheng SY, Nagy A, Park YJ, Alitalo K, Shong M, Koh GY.

EMBO Mol Med. 2017 Jun;9(6):750-769. doi: 10.15252/emmm.201607341.

13.

Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.

Park JW, Zhao L, Willingham MC, Cheng SY.

Am J Cancer Res. 2017 Mar 1;7(3):727-739. eCollection 2017.

14.

Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer.

Enomoto K, Zhu X, Park S, Zhao L, Zhu YJ, Willingham MC, Qi J, Copland JA, Meltzer P, Cheng SY.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2268-2280. doi: 10.1210/jc.2016-3771.

15.

Regeneration of thyroid follicles from primordial cells in a murine thyroidectomized model.

Lee J, Yi S, Chang JY, Kang YE, Kim HJ, Park KC, Yang KJ, Sul HJ, Kim JO, Yi HS, Zhu X, Cheng SY, Shong M.

Lab Invest. 2017 Apr;97(4):478-489. doi: 10.1038/labinvest.2016.158. Epub 2017 Jan 23.

16.

Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.

Zhu X, Enomoto K, Zhao L, Zhu YJ, Willingham MC, Meltzer P, Qi J, Cheng SY.

Clin Cancer Res. 2017 Jan 15;23(2):430-440. doi: 10.1158/1078-0432.CCR-16-0914. Epub 2016 Jul 20.

17.

SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.

Zhu X, Kim DW, Zhao L, Willingham MC, Cheng SY.

Endocr Relat Cancer. 2016 Jul;23(7):521-33. doi: 10.1530/ERC-16-0103. Epub 2016 Jun 7.

18.

Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.

Park JW, Zhao L, Willingham MC, Cheng SY.

Mol Carcinog. 2017 Feb;56(2):489-498. doi: 10.1002/mc.22511. Epub 2016 Jun 14.

PMID:
27254276
19.

Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.

Park J, Kim WG, Zhao L, Enomoto K, Willingham M, Cheng SY.

Oncotarget. 2016 Jun 7;7(23):34832-44. doi: 10.18632/oncotarget.8989.

20.

Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage.

Sayre NL, Sifuentes M, Holstein D, Cheng SY, Zhu X, Lechleiter JD.

J Cereb Blood Flow Metab. 2017 Feb;37(2):514-527. doi: 10.1177/0271678X16629153. Epub 2016 Jul 20.

Supplemental Content

Loading ...
Support Center